Home›Companies›Healthcare›Synvitrobio

Synvitrobio, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 22, 2023·Suggest an edit

About Synvitrobio

Synvitrobio is a private company based in San Leandro, California. It has reported $17,556,003 raised in one offering on Form D since September 2023. Its chief executive is Michael Nemzek.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 8, 2023Sep 22, 2023$17,556,003fully sold16$1.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Synvitrobio's Form D filed Sep 22, 2023.

MN
Michael Nemzek
CEO and director
ZS
Zachary Sun
Executive officer and director
CC
Corinna Chen
Director

Sources

  1. SECSynvitrobio, Inc. filing history